MSL
GEN

Mackay Shields LLC’s Genesis Healthcare, Inc. GEN Stock Holding History

Mackay Shields LLC’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-78,300
Closed -$113K – 1553
2019
Q1 		$113K Buy
78,300
+28,300
+57% +$42K ﹤0.01% 1359
2018
Q4 		$59K Buy
+50,000
New +$74.2K ﹤0.01% 1360

Other funds holding GEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Mackay Shields LLC's GEN Position: Q2 2019 in Review

Mackay Shields LLC sold out of Genesis Healthcare, Inc. (GEN) in Q2 2019, closing a stake of 78,300 shares — an estimated $113K sold.

Mackay Shields LLC first reported a position in GEN in Q4 2018 and held it in 2 quarters. The position peaked at $113K in Q1 2019. 77 funds tracked by Wall St. Rank hold GEN as of Q2 2019.

  • Mackay Shields LLC reported no remaining Genesis Healthcare, Inc. position as of Q2 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 78,300 Genesis Healthcare, Inc. shares in Q2 2019, an estimated $113K.
  • Mackay Shields LLC first reported a position in Genesis Healthcare, Inc. in Q4 2018 and held it in 2 quarters.
  • Mackay Shields LLC's Genesis Healthcare, Inc. position peaked at $113K in Q1 2019.
  • 77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2019.

Based on Mackay Shields LLC's 13F filing for Q2 2019, filed 13 Aug 2019.